This review will focus on the development of vaccines against influenza A/H5N1 strains. Reducing the impact of the potential pandemic would entail pharmaceutical and nonpharmaceutical interventions.

Life science companies developing bird flu vaccines and antivirals are gaining attention as the avian influenza subtype H5N1 becomes an increasing concern.

If we don’t invest in technologies like mRNA vaccines for pandemic influenza now, once a virus starts going human-to-human, ...

The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

While H5N1 does not have high mortality rates in dairy cows, the infection causes decreases milk production and milk quality, ...

According to the CDC, there has been a decline in animal infections and no reports of human cases since February.

Arboviruses are spreading beyond tropical and subtropical regions due to climate change, population growth, and increased ...

From the outset of the Trump administration, bird flu, or H5N1 avian influenza, has flown rather conspicuously — and in fact ...

During his Senate confirmation hearings, Health Secretary Robert F. Kennedy Jr. suggested he wouldn’t undermine vaccines. “I am not going to go into HHS and impose my preordained opinions on anybody ...

Preteens were more likely to get vaccinated against human papillomavirus (HPV) if their parents were given reminder letters ...

Short sellers started to panic in recent days. Moderna (MRNA), which has a short interest of 16.44%, might benefit from two ...